|

CXR Biosciences is committed to accelerating drug development, reducing late stage product attrition, and accurately determining the safety characteristics of chemicals....
 

CXR Biosciences: your partner in problem solving

At CXR, we combine proprietary technologies and world-class scientific expertise to deliver tailored preclinical services:

By providing expert services and developing innovative technologies, CXR Biosciences can help you:

· ..improve the clinical predictability of drug discovery ADMET screens
· ..reduce late stage product attrition
· ..rescue chemicals and drugs that may otherwise be abandoned
· ..transform human risk assessment of drugs and chemicals




  Drug-drug interaction study using triple humanized mous..
CXR Biosciences Ltd and Taconic are pleased to announce the publication of a collaborative study with the Japanese Pharmaceutical company Kyowa Hakko ... »
  CXR Biosciences is a partner in a ten million Euro R&D ..
CXR Biosciences Ltd today announced they will be joining with other partners in a five year joint research and development project which is now enteri... »
  Non-genotoxic carcinogenicity study accepted for public..
CXR Biosciences Ltd and TaconicArtemis GmbH are pleased to announce that the prestigious Toxicological Sciences Journal has accepted for publication a... »
 

© Copyright CXR Biosciences Scotland 2007 | James Lindsay Place, Dundee Technopole, Dundee, Scotland DD1 5JJ Tel +44 1382 432163
Web Design, Development and hosting by MTC Media